Intraoperative NIRS of Transplanted Kidney for Prediction of Acute and Sub-acute Injury
Phase 3
- Conditions
- Graft Failure
- Registration Number
- NCT04685174
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Brief Summary
This is a prospective, observational cohort study, designed to explore the use of NIRS in kidney transplants. This study will investigate an association between measurements of intra- operative NIRS and post - operative graft dysfunction as manifested in initiation of renal replacement therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Kidney transplant candidates (living/ cadaver donor) at TLVMC who will consent to participate.
Exclusion Criteria
- Patients unable to give consent,
- patients whose surgeries were aborted before transplant,
- patients who were lost to follow up during the first 7 post-transplant days,
- patients who suffered from surgical graft failure (vascular problems or need for re exploration due to bleeding etc.)
- No pregnant patients will participate in this study.
- No minors will participate in this study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Graft Failure 6 months post operative Initiation of renal replacement therapy
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie NIRS detection of kidney graft injury in NCT04685174?
How does intraoperative NIRS compare to standard-of-care assessments for predicting kidney injury post-transplant?
Which biomarkers correlate with NIRS measurements in transplanted kidneys to predict graft dysfunction?
What adverse events are associated with intraoperative NIRS monitoring during kidney transplantation?
Are there combination therapies or alternative technologies that enhance NIRS-based kidney injury prediction?